This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Xeljanz
  • /
  • A Phase 2b, Multi-site, Randomized, Double-blind, ...
Clinical trial

A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasi

Read time: 2 mins
Last updated:30th Apr 2013
Identifier: NCT01831466
The study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis. Two dose strengths of tofacitinib ointment (20 mg/g and 10 mg/g) applied once or twice daily are being tested. The safety and effectiveness of tofacitinibointment used for 12 weeks will be compared to the safety and effectiveness of placebo ointment (vehicle) used for 12 weeks.
Category Value
Date last updated at source 2015-10-26
Study type(s) Interventional
Expected enrolment 476
Study start date 2013-05-01
Estimated primary completion date 2014-09-01

View full details